Effectiveness of tissue-type plasminogen activator for acute ischemic stroke: Consequences of protocol violation

Effectiveness of tissue-type plasminogen activator for acute ischemic stroke: Consequences of protocol violation

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Karbalai, H, Demchuk, A, Hoyte, K, Klein, G, Feasby, T, Buchan, A
Μορφή:	Journal article
Έκδοση:	1999

Παρόμοια τεκμήρια

Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.
ανά: Buchan, A, κ.ά.
Έκδοση: (2000)

Treatment of the patient with acute ischemic stroke
ανά: Klein, G, κ.ά.
Έκδοση: (1998)

Stroke thrombolysis: is tissue plasminogen activator a defibrillator for the brain?
ανά: Buchan, A, κ.ά.
Έκδοση: (2000)

Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke.
ανά: Demchuk, A, κ.ά.
Έκδοση: (1999)

Does the application of X-ray contrast agents impair the clinical effect of intravenous recombinant tissue-type plasminogen activator in acute ischemic stroke patients?
ανά: Dzialowski, I, κ.ά.
Έκδοση: (2012)

Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada
ανά: Demaerschalk, B, κ.ά.
Έκδοση: (2003)

Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.
ανά: Hill, MD, κ.ά.
Έκδοση: (2000)

Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.
ανά: Wang, X, κ.ά.
Έκδοση: (2004)

Complications associated with recombinant tissue plasminogen activator therapy for acute ischaemic stroke.
ανά: Balami, J, κ.ά.
Έκδοση: (2013)

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
ανά: Tanne, D, κ.ά.
Έκδοση: (2002)

The neurotoxicity of tissue plasminogen activator?
ανά: Kaur, J, κ.ά.
Έκδοση: (2004)

Biochemistry of ischemic stroke.
ανά: Barber, P, κ.ά.
Έκδοση: (2003)

Strategies for therapy in acute ischemic stroke.
ανά: Buchan, A, κ.ά.
Έκδοση: (2007)

The rise and fall of NMDA antagonists for ischemic stroke.
ανά: Hoyte, L, κ.ά.
Έκδοση: (2004)

Time is brain: Post-marketing experience with alteplase (tPA) for acute ischemic stroke
ανά: Hill, MD, κ.ά.
Έκδοση: (2000)

Organised stroke care increases the numbers and the speed with which patients with acute ischemic stroke are thrombolysed
ανά: Kennedy, J, κ.ά.
Έκδοση: (2002)

Reactions to alteplase in patients with acute thrombotic stroke - Reply
ανά: Hill, MD, κ.ά.
Έκδοση: (2000)

Complications of endovascular treatment for acute ischemic stroke
ανά: Balami, J, κ.ά.
Έκδοση: (2017)

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.
ανά: Hill, MD, κ.ά.
Έκδοση: (2005)

Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke.
ανά: Hill, MD, κ.ά.
Έκδοση: (2000)

Informed consent for thrombolytic therapy in acute ischemic stroke.
ανά: Sivakumar, C, κ.ά.
Έκδοση: (2005)

Acute ischaemic stroke. Thrombolysis for acute ischaemic stroke works.
ανά: Hill, MD, κ.ά.
Έκδοση: (2000)

Tissue outcome in acute ischemic stroke: how useful is perfusion?
ανά: Harston, G, κ.ά.
Έκδοση: (2013)

Is glucose a predictor of hemorrhage after rtPA therapy in acute stroke?
ανά: Demchuk, A, κ.ά.
Έκδοση: (1998)

Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians.
ανά: Mateen, F, κ.ά.
Έκδοση: (2010)

Does application of radio contrast media prior to thrombolysis impact thrombolytic effect in acute ischemic stroke?
ανά: Dzialowski, I, κ.ά.
Έκδοση: (2008)

Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke.
ανά: Alexandrov, A, κ.ά.
Έκδοση: (2004)

Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke.
ανά: Hill, MD, κ.ά.
Έκδοση: (2002)

Reply: Thrombolysis in acute ischaemic stroke.
ανά: Balami, J, κ.ά.
Έκδοση: (2014)

An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke.
ανά: Coutts, S, κ.ά.
Έκδοση: (2008)

Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.
ανά: Simon, J, κ.ά.
Έκδοση: (2004)

Intra-arterial therapy following intravenous alteplase for severe ischemic stroke
ανά: Hill, MD, κ.ά.
Έκδοση: (2001)

Thrombolysis for acute ischemic stroke in patients older than 80 years
ανά: N, S, κ.ά.
Έκδοση: (2006)

Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia.
ανά: Klein, G, κ.ά.
Έκδοση: (1999)

Sonothrombolysis for acute ischemic stroke treatment
ανά: Chen, Runyang
Έκδοση: (2014)

Sonothrombolysis for acute ischemic stroke treatment
ανά: Loy, Yao Shan.
Έκδοση: (2013)

Thrombolytic therapy for acute ischemic stroke - The CAEP Position Statement: another perspective.
ανά: Hill, MD, κ.ά.
Έκδοση: (2001)

Is intravenous recombinant plasminogen activator effective up to 4.5 h after onset of ischemic stroke?
ανά: Rothwell, P
Έκδοση: (2009)

Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging.
ανά: Coutts, S, κ.ά.
Έκδοση: (2005)

Understanding and managing ischemic stroke.
ανά: Barber, P, κ.ά.
Έκδοση: (2001)